Erytech Pharma SA (ADR) - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
ERYP Nasdaq 2836 http://erytech.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Erytech Pharma SA (ADR)

Monthly information related to total number of voting rights and shares composing the share capital _February 28, 2023 - Mar 6th, 2023 5:00 pm
ERYTECH and PHERECYDES Announce Proposed Combination Intending to Create Global Leader in Extended Phage Therapies - Feb 15th, 2023 9:30 pm
Monthly information related to total number of voting rights and shares composing the share capital _January 31, 2023 - Feb 9th, 2023 5:00 pm
Monthly information related to total number of voting rights and shares composing the share capital _December 31, 2022 - Jan 9th, 2023 5:00 pm
Monthly information related to total number of voting rights and shares composing the share capital _November 30, 2022 - Dec 6th, 2022 5:00 pm
Monthly information related to total number of voting rights and shares composing the share capital _October 30, 2022 - Dec 6th, 2022 5:00 pm
ERYTECH Provides Business and Financial Update for the Third Quarter of 2022 - Nov 21st, 2022 9:05 pm
ERYTECH Announces Receipt of Nasdaq Notice - Oct 13th, 2022 8:05 pm
Erytech Pharma SA Sponsored ADR (ERYP) Upgraded to Buy: Here's Why - Oct 5th, 2022 4:00 pm
Monthly information related to total number of voting rights and shares composing the share capital _September 30, 2022 - Oct 4th, 2022 4:00 pm
ERYTECH Provides Business and Financial Update for the First Half of 2022 - Sep 12th, 2022 8:05 pm
Monthly information related to total number of voting rights and shares composing the share capital _August 31, 2022 - Sep 6th, 2022 8:30 pm
Monthly information related to total number of voting rights and shares composing the share capital _July 31, 2022 - Sep 6th, 2022 8:30 pm
Erytech (ERYP) Stops Developing Drug in Leukemia, Down 19.6% - Aug 26th, 2022 5:21 pm
Erytech Pharma Culls Work On Late-Stage Leukemia Asset, Evaluates Partnership Options - Aug 25th, 2022 10:35 am
ERYTECH Provides Regulatory Update - Aug 24th, 2022 8:05 pm
Monthly information related to total number of voting rights and shares composing the share capital _June 30, 2022. - Jul 7th, 2022 4:00 pm
Report – ERYTECH’s Combined Shareholders’ Meeting On June 24, 2022 - Jun 24th, 2022 8:05 pm
Monthly information related to total number of voting rights and shares composing the share capital _May 31, 2022. - Jun 3rd, 2022 4:00 pm
ERYTECH Announces the Availability of the Documents for its Annual General Meeting to be held on June 24, 2022 - May 24th, 2022 8:05 pm